The 21 analysts offering 12-month price forecasts for Amgen Inc have a median target of 252.00, with a high estimate of 295.00 and a low estimate of 182.00. The median estimate represents a +8.78% increase from the last price of 231.65.
The current consensus among 27 polled investment analysts is to Hold stock in Amgen Inc. This rating has held steady since August, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $4.45
Reporting Date Nov 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.